Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating and disseminated tumor cells

Stephan Braun1, Bjørn Naume

  • 1Innsbruck Medical University, Department of Obstetrics and Gynecology, Breast Health Center, Anichstrasse 35 A-6020 Innsbruck Austria. stephan.braun@uklibk.ac.at

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 10, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translating CLEOPATRA into routine practice: National treatment patterns and survival for patients with HER2-positive metastatic breast cancer.

Breast (Edinburgh, Scotland)·2026
Same author

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 6118.

Cancers·2026
Same author

The impact of motivation to lead on team outcomes: the mediating role of leaders' role satisfaction in China and Germany.

Frontiers in psychology·2025
Same author

Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment.

International journal of cancer·2025
Same author

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

BMJ open·2025
Same author

Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy.

Molecular oncology·2025